Buy (150 RUB)
Generate QR code
Open Access
Subscription or Fee Access
Clinical and laboratory markers of structural and functional disorders in the formation of chronic kidney disease in young children, treatment effectiveness
https://doi.org/10.21508/1027-4065-2024-69-4-70-78
Abstract
Diseases of the urinary system in children are a pressing problem due to the development of chronic kidney disease.
Purpose. To identify predictors of the development of chronic kidney disease in young children, develop a treatment and rehabilitation complex and evaluate its effectiveness based on the dynamics of structural and functional disorders of the urinary system.
Material and methods. 69 children (14.5 ± 9.6 months) with aged kidney diseases and 35 children (11.7 ± 5.9 months) of the control group without kidney disease were examined.
Results. 76.1 % of children have chronic secondary pyelonephritis, their likelihood increases if the mother has a history of pathology of the placenta the blood and digestive organs; when these are combined with gestational diabetes mellitus, there are relationships with congenital hydronephrosis, pyelocalicectasia, vesicoureteral reflux, with a reliability of the model of 86 %. Relationships between VEGF-A and urinary syndrome, indicators of renal blood flow in children with unfavorable maternal medical history factors were found.
Conclusion. Somatic pathology, diseases of the placenta and gestational diabetes mellitus in the mother’s history increase the likelihood of pathology of the urinary system and are associated with hydronephrosis, pyelocalicoectasia, vesicoureteral reflux in children. VEGF-A levels may be markers of an unfavorable or favorable course of pyelonephritis. 26 % of children with secondary pyelonephritis require surgical correction. The complex, including antibiotics, calcium metabolism regulators, diuretics of plant origin (Canephron N), physiotherapy, influenced the restoration of the structures and functions of the kidneys.
Keywords
Young children,
vasculoendothelial factor,
chronic pyelonephritis,
congenital anomalies of the urinary system,
Canephron N
Supporting agencies: The authors of this article confirmed the lack other of conflict of interest, which should be reported
About the Authors
E. V. Safina
Urals State Medical University
Russian Federation
Russian Federation
Ekaterinburg
I. A. Plotnikova
Urals State Medical University
Russian Federation
Russian Federation
Ekaterinburg
V. L. Zelentsova
Urals State Medical University
Russian Federation
Russian Federation
Ekaterinburg
V. V. Bazarnyi
Urals State Medical University
Russian Federation
Russian Federation
Ekaterinburg
N. G. Grushina
Urals State Medical University
Russian Federation
Russian Federation
Ekaterinburg
References
1. Soylemezoglu O., Duzova A., Yalçinkaya F., Süleymanlar G. Chronic renal disease in children aged 5–18 years: a population-based survey in Turkey, the CREDIT-C study. Nephrol Dial Transplantat 2012; 3: 146–151. DOI: 10.1093/ndt/gfs366
2. Healthcare in Russia, 2021 : statistical collection. Federal State Statistics Service. Moscow, 2021; 171. (in Russ.) https://rosstat.gov.ru/storage/media-bank/Zdravoohran-2021.pdf/
3. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 1999; 7: 527–543. DOI: 10.1007/s001099900019
4. Wenger R.H., Kvietikova I., Rolfs A., Gassmann M., Marti H. Hypoxia-inducible factor-1 alpha is regulated at the post-mRNA level. Kidney Int 1997; 2: 560–563. URL: https://www.kidney-international.org/article/S0085-2538(15)59919-5/pdf
5. Bazarnyi V.V., Avertchenko M.V. The clinical diagnostic importance of detection of vascular endothelial growth factor in evaluation of progression of pyelonephritis in children. Klinicheskaya laboratornaya diagnostika 2014; 2: 26–40. (in Russ.)
6. Morozov D.A., Morrison V.V., Morozova O.L., Lakomova D.Yu. Pathogenic basis and modern prospects in early diagnostics of nephrosclerosis in children with vesicoureteral reflux. Saratovskii nauchno-meditsinskii zhurnal 2011; 7(1): 151–157. (in Russ.)
7. Ivanov V.V., Saganov V.P. Pharmacoeconomic effectiveness of phytotherapy in complex treatment of pyelonephritis. Acta Biomedica Scientifica 2015; 2(102): 12–14. (in Russ.)
8. Safronova E.S., Sokolova Ja.S., Lishik I.A., Pul’man A.V., Mel’nik P.A. The use of Kanefron for preventive purposes during pregnancy with a disease of the urinary system (pyelonephritis). Dostizheniya nauki i obrazovaniya 2019; 5(46): 98–103. (in Russ.)
9. Gao A., Cachat F., Faouzi M., Bardy D., Mosig D., Meyrat B.J. et al. Comparison of the glomerular filtration rate in children by the new revised Schwartz formula and a new generalized formula. Kidney Int 2013; 3: 524–530. DOI: 10.1038/ki.2012.388
10. Lehr R. Sixteen s-squared over d-squared: A relation for crude sample size estimates. Statistics Med 1992; 8: 1099–1102. DOI: 10.1002/sim.4780110811
11. Bonello M., Ratanarat R., Salvatori G., Van-Straaten H.O., Bellomo R., Ronco C. Pathophysiology of acute renal failure. In: Replacement of Renal Function by Dialysis. Editors Hörl W.H., Koch K.M., Lindsay R.M., Ronco C., Winchester J.F. Springer, Dordrecht. 2004. DOI: 10.1007/978–1–4020–2275–3_8
12. Bartoli F., Pastore V., Calè I., Aceto G., Campanella V., Lasalandra C. et al. Prospective Study on Several Urinary Biomarkers as Indicators of Renal Damage in Children with CAKUT. Eur J Pediatr Surg 2019; 2: 215–222. URL: https://www.researchgate.net/publication/324958642_Prospective_Study_on_Several_Urinary_Biomarkers_as_Indicators_of_Renal_Damage_in_Children_with_CAKUT
13. Yoo J., Je B.K., Choo J.Y. Ultrasonographic Demonstration of the Tissue Microvasculature in Children: Microvascular Ultrasonography Versus Conventional Color Doppler Ultrasonography. Korean J Radiol 2020; 2: 146–158. DOI: 10.3348/kjr.2019.0500
14. Zorin I.V., Vyalkova A.A. Prediction of progression of tubulointerstitial damage in children with reflux nephropathy. Nefrologiya 2015; 19(3): 65–71. (in Russ.)
15. Kamon Y., Takeuchi T. Molecularly Imprinted Nanocavities Capable of Ligand-Binding Domain and Size/Shape Recognition for Selective Discrimination of Vascular Endothelial Growth Factor Isoforms 2018; 3: 580–586. DOI: 10.1021/acssensors.7b00622
16. Uccelli A., Wolff T., Valente P., Di Maggio N., Pellegrino M., Gürke L. et al. Vascular endothelial growth factor biology for regenerative angiogenesis. Swiss Med Wkly 2019;149: w20011. DOI: 10.4414/smw.2019.20011
17. Yakovleva N.Yu., Khazova E.I., Vasil’eva E.Yu., Zazerskaya I.E. Ratio of angiogenic and anti-angiogenic factors in preeclampsia. Arterial’naya Gipertenziya 2016; 22(5): 488–494. (in Russ.) DOI: 10.18705/1607–419X-2016–22–5–488–494
18. Stepanova T.V., Ivanov A.N., Popyhova E.B., Lagutina D.D. Molecular markers of endothelial dysfunction. Modern problems of science and education. (in Russ.) URL: https://elibrary.ru/download/elibrary_37031896_21333444.pdf
19. Han M.A., Novikova E.V. Rehabilitation treatment of children with chronic pyelonephritis. Pediatriya. Zhurnal im. G.N. Speranskogo 2011; 90 (3): 128–131. (in Russ.)
Review
For citations:
Safina E.V., Plotnikova I.A., Zelentsova V.L., Bazarnyi V.V., Grushina N.G. Clinical and laboratory markers of structural and functional disorders in the formation of chronic kidney disease in young children, treatment effectiveness. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2024;69(4):70-78. (In Russ.) https://doi.org/10.21508/1027-4065-2024-69-4-70-78
Views:
372
Email this article 